Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September.

HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements

“Given the interdependency of the pharmaceutical supply chain, successful implementation of the DSCSA is predicated on all trading partners having systems and procedures tested and ready to go for unit-level serialization," adds HDA's Chip Davis, Jr.

Hda Statement Dscsa Enforcement

The Healthcare Distribution Alliance (HDA) released a statement from president and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements:

“FDA’s determination to exercise enforcement discretion for the DSCSA’s November 27 deadline puts the health and safety of Americans first. While progress has been made among trading partners to reach full implementation, more work remains, and numerous issues are still ongoing. HDA distributor members, in partnership with manufacturers and dispensers, will use the additional time to ensure the ability to send and accept serialized products and the corresponding electronic data fields necessary to fully implement the DSCSA.

“In June, HDA recommended an approach to the final stages of DSCSA implementation to minimize the potential for supply disruptions and interruptions to patient care. Given the state of readiness across the supply chain and the law’s single compliance date for all trading partners, HDA made this proposal to avoid what could become a problematic situation later this year. The agency heard the concerns of distributors, manufacturers and pharmacists and provided guidance that will ultimately minimize the potential for disruptions in the short term. 

“Given the interdependency of the pharmaceutical supply chain, successful implementation of the DSCSA is predicated on all trading partners having systems and procedures tested and ready to go for unit-level serialization. HDA is proud of the collaboration between the public and private sectors as well as FDA that led to the release of this guidance, and we look forward to continuing this work at our upcoming Traceability Seminar.

“Looking ahead, HDA will continue to bring together supply chain partners, FDA and other stakeholders to align on a workable path forward to final implementation. Working together, we can help make sure that the DSCSA is implemented in the manner that Congress intended in 2013 — without undermining the stability of the supply chain on which Americans depend."  

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report